- Home
- MIST vs LNSR Comparison
MIST vs LNSR Comparison
Compare MIST & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIST | LNSR |
|---|---|---|
| Founded | 2003 | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Electronics |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 146.7M |
| IPO Year | 2019 | 2005 |
Fundamental Metrics
Financial Performance| Metric | MIST | LNSR |
|---|---|---|
| Price | $1.91 | $5.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $8.00 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 2.9M | 108.1K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $58,435,000.00 |
| Revenue This Year | $2,915.14 | $10.06 |
| Revenue Next Year | N/A | $41.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $1.00 | $5.19 |
| 52 Week High | $3.06 | $14.26 |
Technical Indicators
Market Signals| Indicator | MIST | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 54.55 | 28.82 |
| Support Level | $1.89 | N/A |
| Resistance Level | $2.30 | $6.39 |
| Average True Range (ATR) | 0.18 | 0.32 |
| MACD | 0.01 | 0.13 |
| Stochastic Oscillator | 46.97 | 1.71 |
Price Performance
Historical ComparisonAbout MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.